[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
Purchase Options:
[Skip to Content Landing]
Views 1,557
Citations 0
Correction
March 1, 2016

Coordinating Clinical Site Omitted

JAMA. 2016;315(9):944. doi:10.1001/jama.2016.1591

In the Original Investigation entitled “Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial” published in the November 24, 2015, issue of JAMA,1 a coordinating clinical site was omitted from eAppendix 1 in Supplement 1: Grand Blanc, MI Retina Vitreous Center (4): Robin D. Ross (I); Susan M. Sanford (C); Nicole Martini Markiewicz (C); Tracy M. Utley (C,V); Shannon Henderson (V); Mary D. Walker (V); Joanie H. Lippincott (P); Patricia Streasick (P). This article was corrected online.

References
1.
Gross  JG, Glassman  AR, Jampol  LM,  et al; Writing Committee for the Diabetic Retinopathy Clinical Research Network.  Panretinal photocoagulation vs intravitreous ranibizumab for proliferative diabetic retinopathy: a randomized clinical trial.  JAMA. 2015;314(20):2137-2146.PubMedArticle
×